BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25542045)

  • 21. Carbapenemase-Producing Organisms: A Global Scourge.
    Bonomo RA; Burd EM; Conly J; Limbago BM; Poirel L; Segre JA; Westblade LF
    Clin Infect Dis; 2018 Apr; 66(8):1290-1297. PubMed ID: 29165604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
    Cercenado E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
    Tängdén T; Giske CG
    J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
    Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
    Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-lactamases in Enterobacteriaceae infections in children.
    Moxon CA; Paulus S
    J Infect; 2016 Jul; 72 Suppl():S41-9. PubMed ID: 27180312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases.
    Pang F; Jia XQ; Wang B; Li YH; Zhao QG
    Pathol Biol (Paris); 2014 Jun; 62(3):152-5. PubMed ID: 24685523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
    Savard P; Carroll KC; Wilson LE; Perl TM
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
    [No Abstract]   [Full Text] [Related]  

  • 28. NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China.
    Zhou G; Guo S; Luo Y; Ye L; Song Y; Sun G; Guo L; Chen Y; Han L; Yang J
    Emerg Infect Dis; 2014 Feb; 20(2):340-2. PubMed ID: 24456600
    [No Abstract]   [Full Text] [Related]  

  • 29. Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae.
    Mathers A
    Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back?
    Voulgari E; Poulou A; Koumaki V; Tsakris A
    Future Microbiol; 2013 Jan; 8(1):27-39. PubMed ID: 23252491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria.
    ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme
    Euro Surveill; 2010 Nov; 15(46):. PubMed ID: 21144433
    [No Abstract]   [Full Text] [Related]  

  • 32. Dissemination of carbapenemase-producing Enterobacteriaceae in France, 2012.
    Dortet L; Cuzon G; Nordmann P
    J Antimicrob Chemother; 2014 Mar; 69(3):623-7. PubMed ID: 24275115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbapenemase-Producing Enterobacteriaceae and Nonfermentative Bacteria, the Philippines, 2013-2016.
    Velasco JM; Valderama MT; Peacock T; Warawadee N; Nogrado K; Navarro FC; Chua D; Apichai S; Sirigade R; Macareo LR; Swierczewski B
    Emerg Infect Dis; 2017 Sep; 23(9):1597-1598. PubMed ID: 28820383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Description of carbapenemase-producing Enterobacteriaceae isolates in a Spanish tertiary hospital. Epidemiological analysis and clinical impact.
    López-González L; Viñuela-Prieto JM; Rodriguez-Avial I; Manzano R; Candel FJ
    Rev Esp Quimioter; 2019 Jun; 32(3):254-262. PubMed ID: 30968674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global spread of New Delhi metallo-β-lactamase 1.
    Poirel L; Hombrouck-Alet C; Freneaux C; Bernabeu S; Nordmann P
    Lancet Infect Dis; 2010 Dec; 10(12):832. PubMed ID: 21109172
    [No Abstract]   [Full Text] [Related]  

  • 36. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
    Demir Y; Zer Y; Karaoglan I
    Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
    Deshpande LM; Jones RN; Fritsche TR; Sader HS
    Microb Drug Resist; 2006; 12(4):223-30. PubMed ID: 17227206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid Blue-Carba test: reduction in the detection time of carbapenemases performed from a 4-hour bacterial lawn.
    Nastro M; Ayora M; García S; Vay C; Famiglietti Á; Rodriguez CH
    J Chemother; 2017 Jun; 29(3):150-153. PubMed ID: 27347714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
    J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.